Skip to main content
Caplight Logo









Alixia

Alixia

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://alixia.com/

Last Round

Early Funding

Sep 1, 2025

Total Funding Raised

$2.33M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Alixia is a biotechnology company that develops therapeutics to combat cancer drug resistance by targeting the tumor ecosystem.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologydrug discoveryoncologytumor microenvironmenttherapeutic compoundscomputational chemistryprecision medicinedrug resistancebiotech platformcomputational biologyr&d servicessmall moleculedrug pipelinepharma partnershipai drug discoveryin silico drug design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alixia Comparables

Compare Alixia with similar companies based on industry and business-model similarity.

Alixia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ResistanceBio
84%
Novasenta
83%
Incendia Therapeutics
82%

Alixia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 1, 2025
Series AJul 23, 2024
AcceleratorMar 29, 2022

Alixia Investors

Notable investors and investment history

Alixia investors
InvestorRounds
ZAKA VCEarly Funding
Y CombinatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors grew 379% MoM, from 135 to 646.

Alixia Filings

Explore SEC and related filing metadata, where available.

Alixia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Alixia's valuation, stock price, and market status.

Is Alixia a public or private company?

Alixia is a private company.

What is the current stock price of Alixia?

Alixia is a private company with no public stock price. No recent secondary market data is available.

How much is Alixia worth (valuation)?

Valuation information for Alixia is not publicly available.

Can I buy Alixia stock?

Alixia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Alixia's last funding round?

Alixia's most recent funding round was Series A on July 23, 2024.

Who are the main investors in Alixia?

Key investors in Alixia include Y Combinator.

Will Alixia IPO soon?

No public IPO plans have been announced for Alixia.

How can I track Alixia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alixia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range3
Year Founded2022
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?